Browsing: approval
Fondazione Telethon announces the positive opinion issued by the Committee for Medicinal Products for Human Use (CHMP) of the European…
BiiodicA leading world CDMO, expands his congratulations to Junshi Biosciences (HKEX-1877, SSE-688180), to receiving the approval of new drugs (ind)…
Pembrolizumab, an immune control point inhibitor, has been approved by the US Food and Drug Administration (FDA) for the treatment…
Johnson & Johnson announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for BALVERSA®▼ (erdafitinib)…